Legend Biotech Corp·4

Jul 2, 4:05 PM ET

Huang Ying 4

4 · Legend Biotech Corp · Filed Jul 2, 2026

Research Summary

AI-generated summary of this filing

Updated

Legend Biotech (LEGN) CEO Huang Ying Gifts 3,382 Shares

What Happened
Huang Ying, CEO of Legend Biotech (LEGN), reported a disposition by gift of 3,382 ordinary shares on 2026-06-30. The shares were reported as disposed at $0.00 per share (total proceeds $0), indicating a bona fide charitable gift rather than a sale for cash.

Key Details

  • Transaction date: 2026-06-30; Form 4 filed: 2026-07-02 (appears timely).
  • Transaction type/code: Gift (G); 3,382 shares disposed; reported price $0.00; total proceeds $0.
  • Footnotes: F2 states this was a bona fide gift to a charitable organization. F1 notes the issuer’s ordinary shares may be represented by ADSs (each ADS = 2 ordinary shares).
  • Shares owned after transaction: not specified in the filing.
  • No tax withholding, option exercise, or open-market sale reported in this filing.

Context
Gifts of shares to charity are common insider transactions for philanthropic or tax-planning purposes and do not necessarily signal the insider’s view of the company’s near-term prospects. Because no cash changed hands, this is different from a sale that would realize proceeds for the insider.

Insider Transaction Report

Form 4
Period: 2026-06-30
Huang Ying
DirectorChief Executive Officer
Transactions
  • Gift

    Ordinary Shares

    [F1][F2]
    2026-06-303,382238,490 total
Footnotes (2)
  • [F1]The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.
  • [F2]Represents a bone fide gift to a charitable organization.
Signature
/s/ James Pepin, Attorney-in-Fact|2026-07-02

Documents

1 file
  • 4
    form4-07022026_040714.xmlPrimary